Similar Items: Molecular epidemiological study of variegate porphyria (VP) to determine the frequency of the founder gene mutation in South Africa
- A molecular investigation into the founder hypothesis for variegate porphyria in South African families
- Investigation of the possible influences of candidate modifier genes on the clinical expression of variegate porphyria (VP)
- Mutation analysis of four genes implicated in iron homeostasis in porphyria cutanea tarda (PCT) patients
- Enzyme studies in variegate porphyria
- Analysis of genetic variants in the 5’ regulatory region of the ALAS1 gene in South African patients with Variegate Porphyria (VP)
- Observations on drug-induced porphyria : with espescial reference to the role of ribonucleic acid
Author: Warnich, L.
- The molecular characterisation of the annexin II gene in pre-eclampsia
- Effect of genetic variants in genes encoding two nuclear receptors (PXR and CAR) on efavirenz levels and treatment outcome in South African HIV-infected females
- Sequence-tagged sites of cDNA clones in Solanum tuberosum and their evaluation as molecular markers in Solanaceae species
- Molecular analysis of GJB2 (connexin 26) and GJB6 (connexin 30) gene mutations in non-syndromic hereditary deafness in South Africa
- Molecular genetic analyses of antipsychotic pharmacogenes in a South African first episode schizophrenia cohort
- Investigating the functional significance of genome-wide variants associated with antipsychotic treatment response in schizophrenia